Recombinant Human SUMO1 /SMT3C Protein (rh SUMO1 / SMT3C) Met 1 - Val 101 (Accession # AAH66306) was produced in E.coli cells at ACROBiosystems.
rh SUMO1 / SMT3C is fused with a polyhistidine tag at the N-terminus, and has a calculated MW of 12.4 kDa. The predicted N-terminus is Met. DTT-reduced Protein migrates as 20 kDa in SDS-PAGE .
Less than 1.0 EU per μg of the rh SUMO1 / SMT3C by the LAL method.
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in 50 mM Tris,150 mM NaCl,pH8.0. Normally Mannitol or Trehalose are added as protectants before lyophilization.
Contact us for customized product form or formulation.
See Certificate of Analysis for reconstitution instructions and specific concentrations.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4oC); After reconstitution under sterile conditions for 3 months (-70oC).
Small ubiquitin-related modifier 1 (SUMO1),a member of the ubiquitin family and SUMO subfamily, is also known as GAP-modifying protein 1 (GMP1), SMT3 homolog 3, ubiquitin-homology domain protein PIC1 and ubiquitin-like protein UBL1,which contains one ubiquitin-like domain. Cleavage of precursor form by SENP1 or SENP2 is necessary for the function of SUMO1. Polymeric SUMO1 chains undergo polyubiquitination by RNF4. SUMO1 may also regulate a network of genes involved in palate development.SUMO1 plays an important role in modulation of NOX activity required for ROS generation.
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.